Heterozygous mutations in EPHB4 are reported to cause CM-AVM2, vein of Galen aneurysmal malformation, LRFH, and central conducting lymphatic anomaly (CCLA), but the mechanisms underlying these different presentations remain unclear (21, 22, 25, 26, 28). Here, EPHB4 is linked to vein of Galen aneurysm.